Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Reference Guide
  /  
5a,3a-Androstanediol
Sign up free to test for 
5a,3a-Androstanediol
.
One login for 30+ lab companies.

5a,3a-Androstanediol

5α,3α-Androstanediol, a metabolite of dihydrotestosterone (DHT), plays a significant role as a neurosteroid, modulating neuronal excitability through positive allosteric modulation of GABA_A receptors, and exhibits anticonvulsant properties. 

It also binds to estrogen receptors, influencing various estrogenic activities, and interacts with GABA_A receptor complexes and dopaminergic neurons in the nucleus accumbens, contributing to its rewarding effects and the potential abuse of anabolic steroids. 

Additionally, 5α,3α-androstanediol serves as a marker for peripheral androgen action, with blood and urine tests used to assess its levels for understanding hormone metabolism and balance.

Biochemical Profile of 5a,3a-Androstanediol

What is 5a,3a-Androstanediol?

5a,3a-Androstanediol is also known as 3alpha-androstanediol, or 3a-androstanediol, or more simply as androstanediol.  [13., 14..]  It is a metabolite of the more potent dihydrotestosterone, or DHT.  [4.] 

The chemical formula of 5a,3a-androstanediol is C19H32O2. It is a 5α-reduced androstane steroid with a 3α-hydroxyl group and a 17β-hydroxyl group.  [14.]

Metabolism of 5a,3a-Androstanediol  [12.]

The primary site for the catabolism of circulating testosterone and its potent derivative, 5α-DHT, is the liver. Testosterone is converted into the inactive metabolite 5β-DHT via the enzyme 5β-reductase. 

Both 5α- and 5β-DHT are further metabolized by the enzyme 3α-HSD into 3α,5α-androstanediol (5a,3a-androstanediol) and 3α,5β-androstanediol, respectively, followed by 17β-reduction to form androsterone and etiocholanolone. 

In peripheral tissues like the skin, 5α-DHT can also convert to its metabolites including 5a,3a-androstanediol.

Within the liver, testosterone, DHT, 3α-androstanediols, androsterone, and etiocholanolone undergo glucuronidation and sulfation, forming hydrophilic conjugates for excretion via urine and bile. 

Due to its significant formation in the skin, blood and urine levels of 5a,3a-androstanediol glucuronide (5a,3a-androstanediol G) serve as markers for peripheral androgen action, with reduced levels observed in men with 5α-reductase deficiency.  The extent of body hair and acne is correlated with 5a,3a-androstanediol G levels.

As a neurosteroid, 5a,3a-Androstanediol is also synthesized in the brain.  [16., 17.]

Functions of 5a,3a-Androstanediol  

5a,3a-Androstanediol as a Neurosteroid  [16., 17.]

A neurosteroid is a type of steroid hormone that is synthesized in the brain and nervous system. These hormones can modulate neuronal activity and influence various brain functions, including mood, cognition, and behavior. 

Neurosteroids can be produced de novo in the brain or derived from peripheral sources.  They act on specific receptors in the brain such as GABA_A receptors, NMDA receptors, and sigma receptors to exert their effects. 

Examples of neurosteroids include allopregnanolone, pregnenolone, and dehydroepiandrosterone (DHEA).  5a,3a-Androstanediol exerts some neurosteroid effects.  [16., 17.]

It plays a crucial role in modulating neuronal excitability, primarily through its positive allosteric modulation of GABA_A receptors. This neurosteroid has been shown to have powerful anticonvulsant properties in mouse models of epilepsy. 

For instance, it can protect against seizures induced by GABA_A receptor antagonists in a dose-dependent manner, suggesting its potential as an endogenous protective agent in the brain.  [16., 17.]

The anticonvulsant effects of 3α-androstanediol are primarily mediated through non-genomic mechanisms, as evidenced by its ability to enhance GABA-activated currents in hippocampal neurons. 

This modulation does not seem to be influenced by androgen receptors, as pretreatment with androgen receptor antagonists does not alter its seizure protection efficacy.  

Additionally, 3α-androstanediol is less potent than some other neurosteroids, but it still significantly contributes to the regulation of neuronal excitability and seizure susceptibility.

Estrogenic Effects of 5a,3a-Androstanediol  [9.]

5a,3a-Androstanediol binds to both ERα and ERβ, influencing various estrogenic activities.  

ERα is predominantly found in tissues such as the uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal gland, while ERβ is more prevalent in the prostate, ovary, lung, bladder, brain, and testis. 

This distribution suggests that 3α-androstanediol could play a role in modulating estrogenic effects in these tissues by interacting with the respective ER subtypes.

Studies have shown that 3α-androstanediol has a binding affinity for estrogen receptors, albeit lower than that of estradiol. This interaction may contribute to its role in regulating neuronal excitability and providing neuroprotection, particularly in the context of seizures and other brain disorders. 

By modulating estrogen receptor activity, 3α-androstanediol can influence a range of physiological processes mediated by these receptors.

Reward Effects of 5a,3a-Androstanediol  [6.]

The rewarding effects of anabolic androgenic steroids (AAS) are not fully understood, but studies indicate that the 5α-reduced metabolite of testosterone, 5a,3a-androstanediol, plays a key role. 

Androgens like testosterone can act on both intracellular steroid receptors and other substrates.  Research suggests that 5a,3a-Androstanediol interacts with γ-aminobutyric acid (GABA)_A receptor complexes (GBRs) and dopaminergic neurons in the nucleus accumbens, areas associated with the brain's reward system.

In animal studies, 5a,3a-androstanediol more than testosterone or its metabolite dihydrotestosterone (DHT), has shown significant effects in conditioning place preference (CPP), a measure of drug reward. 

Additionally, lesions in the nucleus accumbens' dopamine neurons prevent 5a,3a-androstanediol-induced CPP, highlighting the importance of dopaminergic pathways in the rewarding effects of 5a,3a-androstanediol.

Overall, these findings suggest that the rewarding effects of testosterone and its metabolites may be significantly influenced by 5a,3a-androstanediol through its actions on GBRs and dopaminergic neurons in the nucleus accumbens, contributing to the abuse potential of anabolic steroids.

5a,3a-Androstanediol as a Hormone Metabolite

As a less biologically-active metabolite of the potent androgen DHT, 5a,3a-Androstanediol may support a healthy and balanced hormone response.  

Additionally, 5a,3a-Androstanediol has some affinity for estrogen receptors, although less than that of other testosterone metabolites including 3beta-androstanediol.  [3., 9.]

Also, 5a,3a-Androstanediol also has a high affinity for sex hormone binding globulin, similar to that of testosterone.  [8.]

Laboratory Testing for 5a,3a-Androstanediol

Overview of Testing, Sample Collection and Preparation

Blood tests are often used to assess levels of 5a,3a-androstanediol levels, typically for endocrine or specialized studies.  Fasting may be required.  [15.] 

Urine samples are also often used for 5a,3a-androstanediol testing, especially in functional medicine settings.  

Androgen metabolites can be excreted in the urine, making it a reliable method for testing androgen processing and comparing ratios of androgenic metabolites.  

Urine testing can aid in understanding an individual’s biochemical preference for the 5-alpha pathway of androgen processing, which produces the more potent DHT, or for the 5-beta pathway, which produces less potent androgenic effects.    

Urine collection can be easier and less stressful for patients compared to blood draws, as samples can be collected at home without the need for a clinical setting.  

Additionally, urinary levels can reflect longer-term hormone exposure rather than the transient levels often seen in blood, as it reflects detoxification patterns (rather than providing snapshots of levels in the bloodstream).

Interpretation of 5a,3a-Androstanediol Test Results

Reference Range for 5a,3a-Androstanediol

It is important to consult with the lab company providing testing for their recommended 5a,3a-androstanediol levels.  For reference, one lab provides the following reference range for urine 5a,3a-androstanediol levels:  [18.]

Female, Postmenopausal: 2.32-8.17 mcg/g 

Optimal Levels of 5a,3a-Androstanediol

Hormones never act alone, and their effects are nuanced.  Optimal levels of 5a,3a-androstanediol in urine tests vary depending on individual health conditions, gender, and age.  Levels should be interpreted within the context of an individual’s health status, and with assessment of other hormone levels.  

Health professionals often recommend that people remain within the reference range of 2.32-8.17 mcg/g for postmenopausal women in urine samples, to maintain optimal hormone levels without experiencing hormone excess or deficiency.  

However, a professional's recommendation will be affected by many factors including the patient’s overall health, detoxification capacity, personal and family health history, time of life, diet and lifestyle, medications, and other factors.  

Regular monitoring through urinary tests is essential to ensure that estrogen metabolite levels are within a safe range, thereby reducing the potential for DNA damage and promoting better hormonal balance and overall health.

Clinical Significance of High 5a,3a-Androstanediol Levels

In postmenopausal women receiving hormone replacement therapy, elevated levels of 5a,3a-androstanediol may indicate an excessive amount of hormone supplementation which may be causing unwanted overstimulation of hormone-sensitive tissue. 

These women should have their dosages assessed by a healthcare professional, and hormone detoxification support may be considered.   

Premenopausal women with elevated levels of 5a,3a-androstanediol should be assessed by a healthcare professional, including a comprehensive assessment of male and female sex hormones, as well as considering adrenal and thyroid hormone levels.  

Additionally, assessment for cardiometabolic markers including blood sugar assessment should be considered if concern for PCOS is present. 

Premenopausal women or women supplementing with testosterone who complain of testosterone excess symptoms should be assessed for testosterone and testosterone metabolite levels.  

See below for more information on natural methods to promote hormone balance.   

Clinical Significance of Low 5a,3a-Androstanediol Levels

Typically, declining levels of testosterone and its metabolites are seen with increasing age.  Testing of androgen metabolites may be recommended for women complaining of symptoms associated with decreasing hormone levels.  

5a,3a-Androstanediol Related Biomarkers

Dihydrotestosterone (DHT)  [11.,19.]

Testing for DHT levels in conjunction with 5a,3a-androstanediol is crucial because 5a,3a-androstanediol is a metabolite of DHT, formed by the action of 3alpha-hydroxysteroid dehydrogenase enzymes.

Measuring both DHT and 5a,3a-androstanediol levels can help assess the activity of this metabolic pathway and its potential impact on androgen-sensitive tissues.  This co-testing is especially important for individuals concerned about prostate health.  

Evaluating these markers together can provide valuable information for understanding androgen-related conditions in the prostate and other tissues.

Testosterone  [11., 19.]

Testosterone is the precursor for the formation of DHT, which is then metabolized to 5a,3a-androstanediol.  Evaluating testosterone levels along with its downstream metabolites, such as DHT and 5a,3a-androstanediol, provides insights into the overall androgen biosynthesis and metabolism. 

This comprehensive assessment can help identify potential dysregulations in androgen production and metabolism that may contribute to altered 5a,3a-androstanediol levels and associated physiological effects.

DHEA  [22.]

DHEA (dehydroepiandrosterone) is a precursor for the synthesis of both testosterone and DHT.  Measuring DHEA levels in conjunction with 5a,3a-androstanediol can help identify potential upstream dysregulations in androgen production that may contribute to altered 5a,3a-androstanediol levels. 

Evaluating DHEA levels along with downstream markers like 5a,3a-androstanediol can provide insights into imbalances in androgen metabolism pathways and their potential consequences.

Natural Ways to Promote Hormone Balance

It is always essential to work with a qualified healthcare professional in any case of hormone imbalance.  The following diet and lifestyle measures have been shown to naturally promote healthy hormone balance:

Dietary Fiber Increase: consuming more fiber helps bind estrogen in the digestive tract, promoting its excretion and reducing reabsorption.  [7.]  

Interestingly, one study of 240 women also showed a correlation between increased fiber intake and anovulation, possibly due to lower estrogen levels.  [7.]

Cruciferous Vegetables: foods like broccoli, cauliflower, and Brussels sprouts contain indole-3-carbinol, which aids in detoxifying excessive estrogen and optimizing hormone balance.  [2.] 

Regular Exercise: physical activity can help balance hormones by improving metabolism and reducing fat, which is significant since body fat can produce and store estrogen.  [21.]

Probiotics and Gut Health: a healthy gut flora supports proper digestion and detoxification processes, including the breakdown, elimination and balance of hormones like estrogen.  [10.]

Limit Alcohol and Caffeine: reducing intake of substances that can impair liver function helps ensure the liver effectively processes and removes excess hormones.  [5., 20.]

Stress Management: stress may have an impact on estrogen levels and metabolism; techniques such as yoga, meditation, or even simple breathing exercises can reduce cortisol levels and help maintain a healthy hormonal balance.  [1.]

Order 5a,3a-Androstanediol Testing

Click here to compare testing options and order tests for 5a,3a-androstanediol levels.  

What's 
5a,3a-Androstanediol
?
5a,3a-Androstanediol, often simply referred to as Androstanediol, is a naturally occurring hormone in your body. It's a byproduct of the powerful male hormone, testosterone. However, it's not just for men - women have it too, just in smaller amounts. This hormone plays a key role in the development and maintenance of male characteristics, but it also has other important functions in both sexes. For instance, it's involved in protein synthesis, which is the process your body uses to build and repair tissues. It also plays a role in your body's energy production, helping to fuel your daily activities. In short, Androstanediol is a vital player in your body's complex hormonal orchestra, contributing to your overall health and well-being.
If Your Levels Are High
High levels of 5a,3a-Androstanediol, or simply Androstanediol, could indicate a variety of conditions or factors. This hormone is a byproduct of testosterone, the primary male sex hormone, but it's also present in women, albeit in smaller amounts. It's crucial for developing and maintaining male traits, but it also plays a significant role in protein synthesis and energy production in both sexes. Therefore, elevated levels could be a sign of increased testosterone production, which might be due to conditions like polycystic ovary syndrome (PCOS) in women or testicular tumors in men. Certain medications, such as anabolic steroids, can also boost testosterone levels, leading to higher Androstanediol. Additionally, lifestyle factors like intense physical training can increase testosterone and subsequently Androstanediol levels. However, it's important to note that these are just potential causes, and the exact reason can vary greatly depending on individual circumstances.
Symptoms of High Levels
Symptoms of high levels of 5a,3a-Androstanediol could include signs of increased testosterone such as acne, hair loss, increased muscle mass, and changes in mood or behavior. In women, symptoms might also include irregular menstrual cycles, excessive hair growth, and weight gain, which are common signs of PCOS. In men, symptoms could include testicular pain or swelling, which might be indicative of a testicular tumor.
If Your Levels are Low
Low levels of Androstanediol, a hormone found in both men and women, could mean your body isn't producing enough testosterone, as this hormone is a byproduct of it. This could potentially affect the development and maintenance of male characteristics. It might also impact your body's ability to build and repair tissues, as Androstanediol is involved in protein synthesis. Additionally, low levels could affect your energy levels, as this hormone plays a role in energy production. Certain medications, like those used to treat high blood pressure or heart conditions, could potentially lower Androstanediol levels. Hormonal imbalances, such as those seen in conditions like hypogonadism or adrenal insufficiency, could also result in lower levels of this hormone.
Symptoms of Low Levels
Symptoms of low levels of 5a,3a-Androstanediol could include fatigue, decreased muscle mass, and reduced libido.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register here.

Register Here
See References

[1.] Assad S, Khan HH, Ghazanfar H, Khan ZH, Mansoor S, Rahman MA, Khan GH, Zafar B, Tariq U, Malik SA. Role of Sex Hormone Levels and Psychological Stress in the Pathogenesis of Autoimmune Diseases. Cureus. 2017 Jun 5;9(6):e1315. doi: 10.7759/cureus.1315. PMID: 28690949; PMCID: PMC5498122. 

[2.] Auborn KJ, Fan S, Rosen EM, et al. Indole-3-Carbinol Is a Negative Regulator of Estrogen. The Journal of Nutrition. 2003;133(7):2470S2475S. doi:https://doi.org/10.1093/jn/133.7.2470s

[3.] Baker ME. Recent insights into the origins of adrenal and sex steroid receptors. J Mol Endocrinol. 2002 Jun;28(3):149-52. doi: 10.1677/jme.0.0280149. PMID: 12063181.

[4.] Dufort I, Labrie F, Luu-The V. Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1. The Journal of Clinical Endocrinology & Metabolism. 2001;86(2):841-846. doi:https://doi.org/10.1210/jcem.86.2.7216

[5.] Emanuele MA, Wezeman F, Emanuele NV. Alcohol's effects on female reproductive function. Alcohol Res Health. 2002;26(4):274-81. PMID: 12875037; PMCID: PMC6676690. 

[6.] Frye CA. Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol. Pharmacol Biochem Behav. 2007 Feb;86(2):354-67. doi: 10.1016/j.pbb.2006.10.003. Epub 2006 Nov 15. PMID: 17112575; PMCID: PMC1857333.

[7.] Gaskins AJ, Mumford SL, Zhang C, et al. Effect of daily fiber intake on reproductive function: the BioCycle Study. The American Journal of Clinical Nutrition. 2009;90(4):1061-1069. doi:https://doi.org/10.3945/ajcn.2009.27990 

[8.] Hong H, Branham WS, Ng HW, Moland CL, Dial SL, Fang H, Perkins R, Sheehan D, Tong W. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. Toxicol Sci. 2015 Feb;143(2):333-48. doi: 10.1093/toxsci/kfu231. Epub 2014 Oct 27. PMID: 25349334.

[9.] Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology. 1997;138(3):863-870. doi:https://doi.org/10.1210/endo.138.3.4979

‌[10.] Maeng LY, Beumer A. Never fear, the gut bacteria are here: Estrogen and gut microbiome-brain axis interactions in fear extinction. International Journal of Psychophysiology. 2023;189:66-75. doi:https://doi.org/10.1016/j.ijpsycho.2023.05.350 

[11.] Marchetti PM, Barth JH. Clinical biochemistry of dihydrotestosterone. Annals of Clinical Biochemistry. 2013;50(2):95-107. doi:https://doi.org/10.1258/acb.2012.012159

[12.] Matsumoto AM, Bremner WJ. Testicular Disorders. Elsevier eBooks. Published online January 1, 2011:688-777. doi:https://doi.org/10.1016/b978-1-4377-0324-5.00019-5

[13.] PubChem. 5alpha-Androstane-3alpha,17beta-diol. pubchem.ncbi.nlm.nih.gov. Accessed May 15, 2024. https://pubchem.ncbi.nlm.nih.gov/compound/5alpha-Androstane-3alpha_17beta-diol

[14.] PubChem. Androstanediol. pubchem.ncbi.nlm.nih.gov. Accessed May 15, 2024. https://pubchem.ncbi.nlm.nih.gov/compound/Androstanediol

[15.] Quest Diagnostics: Test Directory. testdirectory.questdiagnostics.com. Accessed May 15, 2024. https://testdirectory.questdiagnostics.com/test/test-detail/92208/3a-androstanediol-glucuronide-elisa?cc=MASTER

[16.] Reddy DS. Anticonvulsant activity of the testosterone-derived neurosteroid 3α-androstanediol. NeuroReport. 2004;15(3):515. Accessed May 15, 2024. https://journals.lww.com/neuroreport/abstract/2004/03010/anticonvulsant_activity_of_the.26.aspx‌

[17.] Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113-37. doi: 10.1016/B978-0-444-53630-3.00008-7. PMID: 21094889; PMCID: PMC3139029.

[18.] Rupa Health.  1.Sex Steroid Metabolites Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1tN-AZcKD5N5QjRMhZRlgIJr61yw6OJU8/view

[19.] Sharifi N. The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer. J Investig Med. 2012 Feb;60(2):504-7. doi: 10.2310/JIM.0b013e31823874a4. PMID: 22064602; PMCID: PMC3262939.

[20.] Sisti JS, Hankinson SE, Caporaso NE, Gu F, Tamimi RM, Rosner B, Xu X, Ziegler R, Eliassen AH. Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1174-83. doi: 10.1158/1055-9965.EPI-15-0246. Epub 2015 Jun 10. PMID: 26063478; PMCID: PMC4526325. 

[21.] Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325. PMID: 23652373; PMCID: PMC3648856.

[22.] Sumińska M, Bogusz-Górna K, Wegner D, Fichna M. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report. Int J Mol Sci. 2020 Jun 29;21(13):4622. doi: 10.3390/ijms21134622. PMID: 32610579; PMCID: PMC7369945.

Test for

5a,3a-Androstanediol

Order, track, and receive results from 30+ labs in one place.